Massachusetts Wealth Management lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 2.1% in the second quarter, Holdings Channel.com reports. The fund owned 13,647 shares of the company’s stock after purchasing an additional 275 shares during the period. Massachusetts Wealth Management’s holdings in GE HealthCare Technologies were worth $1,011,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new position in GE HealthCare Technologies in the first quarter worth $25,000. Bogart Wealth LLC raised its holdings in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC raised its holdings in GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after purchasing an additional 222 shares in the last quarter. Olde Wealth Management LLC bought a new position in GE HealthCare Technologies in the first quarter worth $35,000. Finally, Zions Bancorporation National Association UT bought a new position in GE HealthCare Technologies in the first quarter worth $42,000. Institutional investors own 82.06% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have issued reports on GEHC. Wall Street Zen downgraded GE HealthCare Technologies from a “buy” rating to a “hold” rating in a report on Saturday, September 20th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their target price for the stock from $93.00 to $83.00 in a research note on Tuesday. Weiss Ratings reissued a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Morgan Stanley set a $74.00 target price on GE HealthCare Technologies in a research note on Thursday, September 18th. Finally, BTIG Research reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Six analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $85.78.
GE HealthCare Technologies Price Performance
NASDAQ GEHC opened at $75.13 on Thursday. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The stock has a 50-day moving average of $74.22 and a 200 day moving average of $72.47. The company has a market capitalization of $34.30 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 2.85 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping the consensus estimate of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same period last year, the company earned $1.00 EPS. GE HealthCare Technologies’s revenue for the quarter was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Best Aerospace Stocks Investing
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- How to Capture the Benefits of Dividend Increases
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- How to Most Effectively Use the MarketBeat Earnings Screener
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.